News

mint Lesion™ in SLK-Clinics Heilbronn

Oncological Therapy Response Assessment at SLK-Clinics Heilbronn: Efficient and Structured Assessements in Daily Routine The SLK-Clinics Heilbronn, a clinic group with about 1,500 beds, are one of the biggest healthcare providers in the region Heilbronn-Franken. The clinic "Diagnostic radiology, minimally-invasive therapies and nuclear medicine" takes...

TNM: Structured Read Procedures for TNM Tumor Staging

  Structured Read Procedures for TNM Tumor Staging The TNM classification for malignancies is the most common approach to document the stage of a cancer disease. TNM staging is basis for planing of therapies, prediction of patient's outcome, identification of appropriate clinical trials, and exchange...

mint Lesion™ in Asia Pacific

Mint Medical GmbH has signed an agreement with Advanced Medical Systems for the distribution of mint Lesion™ in Singapore, India, Malaysia, and Australia mint Lesion™ has been developed to suit the increasingly complex needs of oncological radiology. It enhances workflows, improves efficiency, and bridges communication…

Mint Medical, Inc.

Mint Medical GmbH to establish US subsidiary Mint Medical, Inc. Due to a significant increase in customers in the USA, Mint Medical GmbH has set up a new subsidiary in North America. Mint Medical, Inc. is a wholly-owned subsidiary of Mint Medical GmbH and is…

Refined PET Imaging Capabilities

Mint Medical to Present Refined PET Imaging Capabilities at RSNA 2013 In time for RSNA 2013, Mint Medical enhances and refines the PET imaging functionality for quantitative assessment of FDG-PET image data. FDG-PET is known to be a pioneer of functional imaging for early estimation…

Case Report: malignant melanoma

Case Report: Multimodal oncologic therapy of the malign melanoma New targeted therapies play an increasingly significant role in the therapy of cancer patients. In combination with advances in medical imaging, opportunities and challenges result for the interdisciplinary therapy setting. Prof. Dr. Heinz-Peter Schlemmer, head of…

Cooperation with Charité and HTW Berlin

Research cooperation: Mint Medical cooperates with the Charité University Medicine Berlin and the HTW Berlin Deeper understanding of the molecular and physiological mechanisms of the disease Multiple Sclerosis (MS) contributes to development of new medication for therapy. Medical image data play an important role in…

mint Lesion™ at Stanford

mint Lesion™ at Stanford School of Medicine Prof. Dominik Fleischmann, Clinical Director of the 3D and Quantitative Imaging Laboratory (3DQ Laboratory) at Stanford University, and his team benefit from quality in quantitative imaging provided by mint Lesion™. “Accurate, reproducible, and standardized assessment of treatment response…

mint Lesion™ in UMC Freiburg

Seamless integration of mint Lesion™ into the radiological IT infrastructure at the University Clinic Freiburg The University Clinic decided on mint Lesion™ for the oncologic therapy evaluation. As workflow solution, mint Lesion™ contributes to a consistent diagnosis and comprehensive documentation for the interdisciplinary therapy setting….

Training program

mint Lesion™ users become proficient with response evaluation criteria in oncological radiology   Structured, guideline-based reporting contributes to quality assurance by standardization and harmonization, and it improves the communication of the results. But even though it ensures objective and reproducible results, standardized therapy monitoring brings…